Liu, Jacqueline Ming <br/><br/>
Phase II and pharmacokinetic study of GL331 in previously treated Chinese gastric cancer patients.  [electronic resource] 

 -  Cancer chemotherapy and pharmacology  May 2002 
 - 425-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0344-5704 
<br/><br/><label>Standard No.: </label>10.1007/s00280-002-0429-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antigens, Neoplasm<br/>Antineoplastic Agents, Phytogenic--adverse effects<br/>DNA Topoisomerases, Type II--biosynthesis<br/>DNA-Binding Proteins<br/>Etoposide--adverse effects<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Immunohistochemistry<br/>Male<br/>Middle Aged<br/>Stomach Neoplasms--drug therapy<br/>Survival Analysis